[
Adam MP, Banka S, Bjornsson HT, Bodamer O, Chudley AE, Harris J, Kawame H, Lanpher BC, Lindsley AW, Merla G, Miyake N, Okamoto N, Stumpel CT, Niikawa N; Kabuki Syndrome Medical Advisory Board. Kabuki syndrome: International consensus diagnostic criteria. J Med Genet 56, 89–95, 2019.
]Search in Google Scholar
[
Backe MB, Andersson JL, Bacos K, Christensen DP, Hansen JB, Dorosz JJ, Gajhede M, Dahlby T, Bysani M, Kristensen LH, Ling C, Olsen L, Mandrup-Poulsen T. The lysine demethylase inhibition protects pancreatic beta cells from apoptosis and improves beta cell function. Mol Cell Endocrinol 460, 47–56, 2018.
]Search in Google Scholar
[
Backe MB, Jin C, Andreone L, Sankar A, Agger K, Helin K, Madsen AN, Poulsen SS, Bysani M, Bacos K, Ling C, Perone MJ, Holst B, Mandrup-Poulsen T. The lysine demethylase KDM5B regulates islet function and glucose homeostasis. J Diabet Res 2019, 5451038, 2019.
]Search in Google Scholar
[
Benjamin JS, Pilarowski GO, Carosso GA, Zhang L, Huso DL, Goff LA, Vernon HJ, Hansen KD, Bjornsson HT. A ketogenic diet rescues hippocampal memory defects in a mouse model of Kabuki syndrome. Proc Natl Acad Sci U S A 114, 125–130, 2017.
]Search in Google Scholar
[
Bjornsson HT, Benjamin JS, Zhang L, Weissman J, Gerber EE, Chen YC, Vaurio RG, Potter MC, Hansen KD, Dietz HC. Histone deacetylase inhibition rescues structural and functional brain deficits in a mouse model of Kabuki syndrome. Sci Transl Med 6, 256ra135, 2014.
]Search in Google Scholar
[
Boniel S, Szymanska K, Smigiel R, Szczaluba K. Kabuki syndrome – clinical review with molecular aspects. Genes (Basel) 12, 468, 2021.
]Search in Google Scholar
[
Bramswig NC, Everett LJ, Schug J, Dorrell C, Liu C, Luo Y, Streeter PR, Naji A, Grompe M, Kaestner KH. Epigenomic plasticity enables human pancreatic α to β cell reprogramming. J Clin Invest 123, 1275–1284, 2013.
]Search in Google Scholar
[
Campbell SA, Begin J, McDonald CL, Vanderkruk B, Stephan TL, Hoffman BG. 3H3K4 trimethylation is required for postnatal pancreatic endocrine cell functional maturation. Diabetes 70, 2568–2579, 2021.
]Search in Google Scholar
[
Chakrabarti S, Francis J, Ziesmann SM, Garmey JC, Mirmira RG. Covalent histone modifications underlie the developmental regulation of insulin gene transcription in pancreatic beta cells. J Biol Chem 278, 23617–23623, 2003.
]Search in Google Scholar
[
Chen F, He X, Luan G, Li T. Role of DNA methylation and adenosine in ketogenic diet for pharmacoresistant epilepsy: Focus on epileptogenesis and associated comorbidities. Front Neurol 10, 119, 2019.
]Search in Google Scholar
[
Demirbilek H, Hussain K. Congenital hyperinsulinism: diagnosis and treatment update. J Clin Res Pediatr Endocrinol 9, 69–87, 2017.
]Search in Google Scholar
[
Dhawan S, Tschen SI, Bhushan A. Bmi-1 regulates the Ink4a/Arf locus to control pancreatic β-cell proliferation. Genes Dev 23, 906–911, 2009.
]Search in Google Scholar
[
Faundes V, Goh S, Akilapa R, Bezuidenhout H, Bjornsson HT, Bradley L, et al. Clinical delineation, sex differences, and genotype-phenotype correlation in pathogenic KDM6A variants causing X-linked Kabuki syndrome type 2. Genet Med 23, 1202–1210, 2021.
]Search in Google Scholar
[
Froimchuk E, Jang Y, Ge K. Histone H3 lysine 4 methyltransferase KMT2D. Gene 627, 337–342, 2017.
]Search in Google Scholar
[
Galcheva S, Demirbilek H, Al-Khawaga S, Hussain K. The genetic and molecular mechanisms of congenital hyperinsulinism. Front Endocrinol (Lausanne) 10, 111, 2019.
]Search in Google Scholar
[
Gibson CE, Boodhansingh KE, Li C, Conlin L, Chen P, Becker SA, Bhatti T, Bamba V, Adzick NS, De Leon DD, Ganguly A, Stanley CA. Congenital hyperinsulinism in infants with Turner syndrome: possible association with monosomy X and KDM6A haploinsufficiency. Horm Res Paediatr 89, 413–422, 2018.
]Search in Google Scholar
[
Gole H, Chuk R, Coman D. Persistent hyperinsulinism in Kabuki syndrome 2: case report and literature review. Clin Pract 6, 848, 2016.
]Search in Google Scholar
[
Heinemann B, Nielsen JM, Hudlebusch HR, Lees MJ, Larsen DV, Boesen T, Labelle M, Gerlach LO, Birk P, Helin K. Inhibition of demethylases by GSK-J1/J4. Nature 514, E1-E2, 2014.
]Search in Google Scholar
[
Hemming S, Cakouros D, Isenmann S, Cooper L, Menicanin D, Zannettino A, Gronthos S. EZH2 and KDM6A act as an epigenetic switch to regulated mesenchymal stem cell lineage specification. Stem Cells 32, 802–815, 2014.
]Search in Google Scholar
[
Hoermann H, El-Rifai O, Schebek M, Lodefalk M, Brusgaard K, Bachmann N, Bergmann C, Roeper M, Welters A, Salimi Dafsari R, Blankenstein O, Mayatepek E, Christesen H, Meissner T, Kummer S. Comparative meta-analysis of Kabuki syndrome with and without hyperinsulinaemic hypoglycaemia. Clin Endocrinol (Oxf) 93, 346–354, 2020.
]Search in Google Scholar
[
Jiang W, Wang J, Zhang Y. Histone H3K27me3 demethylases KDM6A and KDM6B modulate definitive endoderm differentiation from human ESCs by regulating WNT signaling pathway. Cell Res 23, 122–130, 2013.
]Search in Google Scholar
[
Jiang Q, Huang X, Hu X, Shan Z, Wu Y, Guangming Wu G, Lei L. Histone demethylase KDM6A promotes somatic cell reprogramming by epigenetically regulating the PTEN and IL-6 signal pathways. Stem Cells 38, 960–972, 2020.
]Search in Google Scholar
[
Kaimala S, Kumar CA, Allouh MZ, Ansari SA, Emerald BS. Epigenetic modifications in pancreas development, diabetes, and therapeutics. Med Res Rev 42, 1343–1371, 2022.
]Search in Google Scholar
[
Kalisz M, Bernardo E, Beucher A, Maestro MA, Del Pozo N, Millán I, Haeberle L, Schlensog M, Safi SA, Knoefel WT, Grau V, de Vas M, Shpargel KB, Vaquero E, Magnuson T, Ortega S, Esposito I, Real FX, Ferrer J HNF1A recruits KDM6A to activate differentiated acinar cell programs that suppress pancreatic cancer. EMBO J 39, e102808, 2020.
]Search in Google Scholar
[
Kostopoulou E, Shah P. Hyperinsulinaemic hypoglycaemia – an overview of a complex clinical condition. Eur J Pediatr 178, 1151–1160, 2019.
]Search in Google Scholar
[
Koutsioumpa M, Hatziapostolou M, Polytarchou C, Tolosa EJ, Almada LL, Mahurkar-Joshi S, Williams J, Tirado-Rodriguez AB, Huerta-Yepez S, Karavias D, Kourea H, Poultsides GA, Struhl K, Dawson DW, Donahue TR, Fernandez-Zapico ME, Iliopoulos D. The histone lysine methyltransferase 2D regulates pancreatic carcino-genesis through metabolic reprogramming. Gut 68, 1271–1286, 2019.
]Search in Google Scholar
[
Kuroki Y, Suzuki Y, Chyo H, Hata A, Matsui I. A new malformation syndrome of long palpebral fissures, large ears, depressed nasal tip, and skeletal anomalies associated with postnatal dwarfism and mental retardation. J Pediatr 99, 570–573, 1981.
]Search in Google Scholar
[
Larsson C. Epigenetic aspects on therapy development for gastroenteropancreatic neuroendocrine tumors. Neuroendocrinology 97, 19–25, 2013.
]Search in Google Scholar
[
Lien YC, Lu XM, Won KJ, Wang PZ, Osei-Bonsu W, Simmons RA. The Transcriptome and epigenome reveal novel changes in transcription regulation during pancreatic rat islet maturation. Endocrinology 162, bqab181, 2021.
]Search in Google Scholar
[
Lintas C, Persico AM. Unraveling molecular pathways shared by Kabuki and Kabuki-like syndromes. Clin Genet 94, 283–295, 2018.
]Search in Google Scholar
[
Longo R, Peri C, Cricri D, Coppi L, Caruso D, Mitro N, De Fabiani E, Crestaniet M. Ketogenic Diet: A new light shining on old but gold biochemistry. Nutrients 9, 11, 2497, 2019.
]Search in Google Scholar
[
Ma R, Wu Y, Li S, Yu X. Interplay between glucose metabolism and chromatin modifications in cancer. Front Cell Dev Biol 9, 654337, 2021.
]Search in Google Scholar
[
Maganti AV, Maier B, Tersey SA, Sampley ML, Mosley AL, Ozcan S. Transcriptional activity of the islet beta cell factor Pdx1 is augmented by lysine methylation catalyzed by the methyltransferases Set 7/9. J Biol Chem 290, 9812–9822, 2015.
]Search in Google Scholar
[
Maines E, Franceschi R, Martinelli D, Soli F, Lepri FR, Piccoli G, Soffiati M. Hypoglycemia due to PI3K/AKT/mTOR signaling pathway defects: two novel cases and review of the literature. Hormones (Athens) 20, 623–640, 2021.
]Search in Google Scholar
[
Maiorana A, Dionisi-Vici C. Hyperinsulinemic hypoglycemia: clinical, molecular and therapeutical novelties. J Inherit Metab Dis 40, 531–542, 2017.
]Search in Google Scholar
[
Maiorana A, Caviglia S, Greco B, Alfieri P, Cumbo F, Campana C, Bernabei SM, Cusmai R, Mosca A, Dionisi-Vici C. Ketogenic diet as elective treatment in patients with drug-unresponsive hyperinsulinemic hypoglycemia caused by glucokinase mutations. Orphanet J Rare Dis 16, 424, 2021.
]Search in Google Scholar
[
Niikawa N, Matsuura N, Fukushima Y, Ohsawa T, Kajii T. Kabuki make-up syndrome: a syndrome of mental retardation, unusual facies, large and protruding ears, and postnatal growth deficiency. J Pediatr 99, 565–569, 1981.
]Search in Google Scholar
[
Pacelli C, Adipietro I, Malerba N, Squeo GM, Piccoli C, Amoresano A, Pinto G, Pucci P, Lee JE, Ge K, Capitanio N, Merla G. Loss of function of the gene encoding the histone methyltransferase KMT2D leads to deregulation of mitochondrial respiration. Cells 9, 1685, 2020.
]Search in Google Scholar
[
Pearson AD, Stegmaier K, Bourdeaut F, Reaman G, Heenen D, Meyers ML, et al. Paediatric Strategy Forum for medicinal product development of epigenetic modifiers for children: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration. Eur J Cancer 139, 135–148, 2020.
]Search in Google Scholar
[
Quilichini E, Haumaitre C. Implication of epigenetics in pancreas development and disease. Best Pract Res Clin Endocrinol Metab 29, 883–898, 2015.
]Search in Google Scholar
[
Revia S, Seretny A, Wendler L, Banito A, Eckert C, Breuer K, et al. Histone H3K27 demethylase KDM6A is an epi-genetic gatekeeper of mTORC1 signalling in cancer. Gut 71, 1613–1628, 2022.
]Search in Google Scholar
[
Sharma S, Gurudutta G. Epigenetic regulation of hematopoietic stem cells. Int J Stem Cells 9, 36–43, 2016.
]Search in Google Scholar
[
Subbarayan A, Hussain K. Hypoglycemia in Kabuki syndrome. Am J Med Genet A. 164A, 467–471, 2014.
]Search in Google Scholar
[
Tran N, Broun A, Ge K. Lysine demethylase KDM6A in differentiation, development, and cancer. Mol Cell Biol 40, e00341–20, 2020.
]Search in Google Scholar
[
Tzika E, Dreker T, Imhof A. Corrigendum: Epigenetics and metabolism in health and disease. Front Genet 2020; 11:428. Erratum for: Front Genet 9, 361, 2018.
]Search in Google Scholar
[
van Arensbergen J, Garcia-Hurtado J, Moran I, Maestro MA, Xu X, Van de Casteele M, Skoudy AL, Palassini M, Heimberg H, Ferrer J. Derepression of Polycomb targets during pancreatic organogenesis allows insulin-producing beta-cells to adopt a neural gene activity program. Genome Res 20, 722–732, 2010.
]Search in Google Scholar
[
Waddington CH. The epigenotype. 1942. Int J Epidemiol 41, 10–13, 2012.
]Search in Google Scholar
[
Wang H, Bender A, Wang P, Karakose E, Inabnet WB, Libutti SK, et al. Insights into beta cell regeneration for diabetes via integration of molecular landscapes in human insulinomas. Nat Commun 8, 767, 2017.
]Search in Google Scholar
[
Xie R, Everett LJ, Lim HW, Patel NA, Schug J, Kroon E, Kelly OG, Wang A, D’Amour KA, Robins AJ, Won KJ, Kaestner KH, Sander M. Dynamic chromatin remodeling mediated by polycomb proteins orchestrates pancreatic differentiation of human embryonic stem cells. Cell Stem Cell 12, 224–237, 2013.
]Search in Google Scholar
[
Xu CR, Li LC, Donahue G, Ying L, Zhang YW, Gadue P, Zaret KS. Dynamics of genomic H3K27me3 domains and role of EZH2 during pancreatic endocrine specification. EMBO J 33, 2157–2170, 2014.
]Search in Google Scholar
[
Yap KL, Johnson AEK, Fischer D, Kandikatla P, Deml PJ, Nelakuditi V, et al. Congenital hyperinsulinism as the presenting feature of Kabuki syndrome: clinical and molecular characterization of 10 affected individuals. Genet Med 21, 233–242, 2019.
]Search in Google Scholar
[
Yi Z, Wei S, Jin L, Jeyarajan S, Yang J, Gu Y, et al. KDM6A regulates cell plasticity and pancreatic cancer progression by noncanonical activin pathway. Cell Mol Gastroenterol Hepatol 13, 643–667, 2022.
]Search in Google Scholar
